Current Edition

Upcoming Events

Advertisement

Current Features

Biotech Sector Survey: From Investment Confidence to Strategic Collaborations

In the rapidly evolving landscape, ICON’s recently published biotech sector survey provides a roadmap through the intricacies of investment confidence, funding dynam...
Continue Reading →
Current Features

Extractables and Leachables for Inhaled Medicines

How risk assessments can improve E&L strategies Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) ar...
Continue Reading →
Current Features

Using Predictive Compliance Risk Analysis to Avoid FDA Penalties

In the complex landscape of global regulations, particularly within healthcare and pharmaceutical sectors, a robust compliance strategy is essential for maintaining ...
Continue Reading →
Current Features

Patients Are Waiting: Speeding Time to Treatment in Rare Disease

Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines faster. Rare diseases are no longer rare. Every year, people’s l...
Continue Reading →
Current Features

Elevating Biomanufacturing Efficiencywith N-1 Perfusion Technology

In the dynamic world of biomanufacturing, the quest for improved efficiency and productivity continues to shape industry advancements. Among these innovations, the e...
Continue Reading →
Current Features

Considerations on the Development and Manufacturing of Generic Peptides

The development of generic versions of peptides such as Semaglutide, the drug substance inside Novo Nordisk’s blockbuster drugs like Ozempic®, Rybelsus® or Wegovy®, ...
Continue Reading →
Current Features

Ensuring Image Integrity When Reviewing Western Blots

Overcoming the Challenges Facing Editors and Publishers Western blots are frequently included in scientific papers to report results when analysing proteins in a ...
Continue Reading →